When viewing Post Market Reports – what is the difference between serious and non-serious reports?
This has more to do with the outcome than the adverse event. Definition of serious (FDA): Death, Life-threatening, Hospitalization (initial or prolonged), Persistent or Significant Disability, Congenital Anomaly, Important Medical Events that may jeopardize the patient and may require medical or surgical intervention to prevent one of the previously-listed outcomes.
PharmaPendium. Make informed drug development decisions.
Interested? Contact us today to find out more about how PharmaPendium could benefit you.
Watch our video to find out how.
